相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Enterotypes in the landscape of gut microbial community composition
Paul I. Costea et al.
NATURE MICROBIOLOGY (2018)
Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome
Julien Tap et al.
GASTROENTEROLOGY (2017)
A Perspective on Brain-Gut Communication: The American Gastroenterology Association and American Psychosomatic Society Joint Symposium on Brain-Gut Interactions and the Intestinal Microenvironment
Olga C. Aroniadis et al.
PSYCHOSOMATIC MEDICINE (2017)
Global Cytokine Profiles and Association With Clinical Characteristics in Patients With Irritable Bowel Syndrome
Sean M. P. Bennet et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)
Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity
Alexandra Zhernakova et al.
SCIENCE (2016)
The relationship between faecal-associated and mucosal-associated microbiota in irritable bowel syndrome patients and healthy subjects
I. Rangel et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells
Christopher S. Reigstad et al.
FASEB JOURNAL (2015)
Altered faecal and mucosal microbial composition in post-infectious irritable bowel syndrome patients correlates with mucosal lymphocyte phenotypes and psychological distress
J. Sundin et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Crosstalk at the mucosal border: importance of the gut microenvironment in IBS
Lena Ohman et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2015)
Cytokine Response after Stimulation with Key Commensal Bacteria Differ in Post-Infectious Irritable Bowel Syndrome (PI-IBS) Patients Compared to Healthy Controls
Johanna Sundin et al.
PLOS ONE (2015)
Faecal microbiota composition and host-microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome
Jonna Jalanka-Tuovinen et al.
GUT (2014)
Chromogranin A as a biomarker of disease activity and biologic therapy in inflammatory bowel disease: a prospective observational study
Athanasios Zissimopoulos et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2014)
Duodenal Chromogranin A Cell Density as a Biomarker for the Diagnosis of Irritable Bowel Syndrome
Magdy El-Salhy et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2014)
Changes of the human gut microbiome induced by a fermented milk product
Patrick Veiga et al.
SCIENTIFIC REPORTS (2014)
The colonic microbiota in health and disease
Fergus Shanahan
CURRENT OPINION IN GASTROENTEROLOGY (2013)
Reduced chromogranin A cell density in the ileum of patients with irritable bowel syndrome
Magdy El-Salhy et al.
MOLECULAR MEDICINE REPORTS (2013)
UPARSE: highly accurate OTU sequences from microbial amplicon reads
Robert C. Edgar
NATURE METHODS (2013)
Serotonin signalling in the gut-functions, dysfunctions and therapeutic targets
Gary M. Mawe et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Altered Levels of Fecal Chromogranins and Secretogranins in IBS: Relevance for Pathophysiology and Symptoms?
Lena Ohman et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Chromogranin A and the Endothelial Barrier Function
A. Corti et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Chromogranin A-Derived Peptides Are Involved in Innate Immunity
R. Aslam et al.
CURRENT MEDICINAL CHEMISTRY (2012)
An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota
Ian B. Jeffery et al.
GUT (2012)
Microscopic colitis: Current status, present and future challenges Statements of the European Microscopic Colitis Group
A. Munch et al.
JOURNAL OF CROHNS & COLITIS (2012)
Chromogranin A cell density in the rectum of patients with irritable bowel syndrome
M. El-Salhy et al.
MOLECULAR MEDICINE REPORTS (2012)
Microbes and the gut-brain axis
P. Bercik et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2012)
Dirichlet Multinomial Mixtures: Generative Models for Microbial Metagenomics
Ian Holmes et al.
PLOS ONE (2012)
Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes
Gary D. Wu et al.
SCIENCE (2011)
The Patient Health Questionnaire 12 Somatic Symptom scale as a predictor of symptom severity and consulting behaviour in patients with irritable bowel syndrome and symptomatic diverticular disease
R. C. Spiller et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Gut hormones: emerging role in immune activation and inflammation
W. I. Khan et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Gastrointestinal-specific anxiety: an important factor for severity of GI symptoms and quality of life in IBS
P. Jerndal et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2010)
GRANINS AS DISEASE-BIOMARKERS: TRANSLATIONAL POTENTIAL FOR PSYCHIATRIC AND NEUROLOGICAL DISORDERS
A. Bartolomucci et al.
NEUROSCIENCE (2010)
The antimicrobial peptides derived from chromogranin/secretogranin family, new actors of innate immunity
Peiman Shooshtarizadeh et al.
REGULATORY PEPTIDES (2010)
Measurements of secretogranins II, III, V and proconvertases 1/3 and 2 in plasma from patients with neuroendocrine tumours
Mats Stridsberg et al.
REGULATORY PEPTIDES (2008)
Chromogranins A and B and secretogranin II: evolutionary and functional aspects
M. Montero-Hadjadje et al.
ACTA PHYSIOLOGICA (2008)
Functional bowel disorders
George F. Longstreth et al.
GASTROENTEROLOGY (2006)
New antimicrobial activity for the catecholamine release-inhibitory peptide from chromogranin A
J Briolat et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2005)
Effect of acetic acid or trypsin application on rat colonic motility in vitro and modulation by two synthetic fragments of chromogranin A
G Jean-Eric et al.
REGULATORY PEPTIDES (2005)
Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome
G Barbara et al.
GASTROENTEROLOGY (2004)
Co-inertia analysis and the linking of ecological data tables
S Dray et al.
ECOLOGY (2003)
Mechanisms of disease - The chromogranin-secretogranin family.
L Taupenot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
The PHQ-15: Validity of a new measure for evaluating the severity of somatic symptoms
K Kroenke et al.
PSYCHOSOMATIC MEDICINE (2002)
分享论文
